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Abstract
Nasturtium(Tropaeolum majus L.) contains high concentrations of benzylglcosinolate. We
found that a hydrolysis product of benzyl glucosinolate—the benzyl isothiocyanate (BITC)—
modulates the intracellular localization of the transcription factor Forkhead box O 1 (FOXO1).
FoxO transcription factors can antagonize insulin effects and trigger a variety of cellular pro-
cesses involved in tumor suppression, longevity, development andmetabolism. The current
study evaluated the ability of BITC—extracted as intact glucosinolate fromnasturtiumand
hydrolyzed withmyrosinase—to modulate i) the insulin-signaling pathway, ii) the intracellular
localization of FOXO1 and, iii) the expression of proteins involved in gluconeogenesis, antiox-
idant response and detoxification. Stably transfected human osteosarcoma cells (U-2OS)
with constitutive expression of FOXO1 protein labeled with GFP (green fluorescent protein)
were used to evaluate the effect of BITC on FOXO1. Human hepatomaHepG2 cell cultures
were selected to evaluate the effect on gluconeogenic, antioxidant and detoxification genes
and protein expression. BITC reduced the phosphorylationof protein kinase B (AKT/PKB)
and FOXO1; promotedFOXO1 translocation from cytoplasm into the nucleus antagonizing
the insulin effect; was able to down-regulate the gene and protein expression of gluconeo-
genic enzymes; and induced the gene expression of antioxidant and detoxification enzymes.
Knockdown analyses with specific siRNAs showed that the expression of gluconeogenic
genes was dependent on nuclear factor (erythroidderived)-like2 (NRF2) and independent of
FOXO1, AKT and NAD-dependent deacetylase sirtuin-1 (SIRT1). The current study provides
evidence that BITCmight have a role in type 2 diabetes T2D by reducing hepatic glucose pro-
duction and increasing antioxidant resistance.
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Introduction
Type 2 diabetes (T2D) is a health problem throughout the world [1]. T2D is characterized by
insulin resistance, which leads to hyperglycemia, owing at least in part to the impaired ability
of insulin to suppress expression or activity of gluconeogenic enzymes [2]. In T2D an increase
in the production of free radicals with a subsequent induction of oxidative stress is also present
[3]. Under oxidative stress conditions the insulin signaling is reduced, which may contribute to
insulin resistance, and to the progression of diabetes and related complications [4–6]. The pres-
ence of reactive oxygen species (ROS) activate the forkhead box O (FOXO) transcription fac-
tors. They mediate the effects of ROS through the modulation of gene transcription factors
involved in several cellular processes including glucosemetabolism, cell cycle arrest, antioxi-
dant response and apoptosis [7], alterations in FOXO function could contribute to metabolic
disorders in diabetes [8]. In humans, FOXO subgroup contains four members: FOXO1,
FOXO3a, FOXO4 and FOXO6 [4]. Since FOXO1 has a variety of cellular functions, in some
cases antagonistic, it is tightly regulated by external stimuli. Environmental signals, including
insulin, growth factors, nutrients, cytokines and oxidative stress induce post-translational
modifications,mainly phosphorylation, acetylation, mono- and poly-ubiquitination which reg-
ulate the levels, subcellular localization, and transcriptional activity of FOXO1 [9].
The translocation of FOXO1 from cytoplasm to the nucleus is mandatory for its transactiva-
tion, which modulates FOXO1 dependent transcription [9]. In the presence of insulin FOXO1
is negatively regulated by AKT/PKB induced-phosphorylation, which causes the sequestration
of FOXO1 in the cytoplasm, thereby preventing FOXO1 from transactivating its target genes
in the nucleus [10]. In the absence of insulin stimulation, during oxidative stress or in the fast-
ing state, FOXO1 may induce oxidative stress resistance through the expression of the anti-oxi-
dant enzymes manganese superoxide dismutase (MnSOD) and catalase (CAT) [11] and
glucose production through the gene expression of phosphoenolpyruvate carboxykinase
(PEPCK) and glucose-6-phosphatase (G6ase) [12]. This metabolic process can be regulated by
mitogen-activated protein kinase phosphatase-3- (MKP-3) mediated dephosphorylation of
FoxO1 at Ser256, which promotes its nuclear import and subsequent recruitment to the pro-
moters of key genes [13]. Phytochemicals, such as the stilbene resveratrol and flavonoids like
apigenin and luteolin have been shown to induce FOXO1 nuclear accumulation and activation
as well, and to promote the gene expression of antioxidant enzymes [11, 14, 15].
Diet plays an important role in the prevention and management of T2D [16] and epidemio-
logical and animal studies have shown that the consumption of some vegetables can delay or
prevent the development of the disease [17]. The evidence for individual dietary components is
scarce, but phytochemicals, a large group of secondarymetabolites of plants used in nutrition,
are thought to play a significant role in the health effects of plant-based diets, although the
underlyingmechanisms of these effects are still unclear [18].
Generally, brassicaceous plants such as Brassica vegetables (e.g. broccoli, cabbage, brussels
sprouts, cauliflower) are marked by a specific group of phytochemicals–the glucosinolates [19].
More than 150 different naturally occurringglucosinolates have been recognized so far, although
their content varies among different vegetables [20]. The Brassicales species nasturtium (Tro-
paeolum majus) is characterized especially by high concentrations of the predominant aromatic
benzyl glucosinolate (1000 mg/100 g fresh matter) [20]. Glucosinolates itself are not the actual
bioactive compounds, but the evidence shows that their corresponding hydrolyses products,
especially isothiocyanates (ITCs), are potent inducers of phase II detoxifying enzymes and subse-
quently confer protection against oxidative stress and chronic inflammation [21].
Despite of the modulatory effect of isothiocyanates on cytoprotective enzymes and inflam-
matory processes, only few studies have linked them with T2D prevention [22]. Recently,
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sulforaphane (4-methylsulfinylbutyl ITC) supplementation extracted from broccoli sprouts
was shown to reduce insulin, inflammatorymarkers and LDL levels in T2D patients [22–24],
although the mechanisms underlying these effects are not clear. AlsoMoringa extracts supple-
mentation rich in 4(α-l-rhamnosyloxy)-benzyl isothiocyanate was shown to display anti-obe-
sity and anti-diabetic properties increasing insulin signaling and sensitivity [25, 26]. According
to the European Prospective Investigation into Cancer and Nutrition (EPIC) the average con-
sumption of aromatic glucosinolates as benzyl glucosinolate varies between the European
countries: 1.4 mg/d (men) to 0.74 mg/d (women) in German population [27], and 4.46 mg/d
(men) to 4.06 mg/d (women) in Spanish population [28], suggesting differently high, but regu-
lar intake of Brassicales species.
Since the PI3/AKT/FOXO1 pathway has a critical role in the metabolic action of insulin,
and FOXO1 is the mediator for gene expression alteration by insulin [29], we developed a fluo-
rescencemicroscopic FOXO1- green fluorescent protein (FOXO1-GFP) translocation assay to
clarify the anti-diabetic properties of ITCs. Therefore, this study evaluated the ability of BITC,
extracted from the edible plant Tropaeolum majus, to modulate the insulin-signaling pathway
and their effects on i) the intracellular localization of FOXO1 and ii) the expression of proteins
involved in glucosemetabolism and antioxidant response. The present study provides detailed
insights into the effect of BITC on the PI3K/AKT/FOXO1 pathway, as BITC is responsible for
FOXO1 nuclear import and accumulation. BITC effect contributes to the antioxidant enzymes
gene expression modulation and gluconeogenesis inhibition, possibly through the interaction
with different nuclear transcription factors from the evaluated in the present study.
Materials andMethods
Cell lines and culture
Cell culturing of human osteosarcoma cell line (U-2 OS) and human hepatocellular carcinoma
cell line (HepG2) was carried out under humid atmosphere, at 37°C with a 5% CO2 content.
The cells were purchased from ECACC (European Animal and Cell Collection).Due to their
more extendedmorphologyU-2 OS cells were used for fluorescence-microscopic analyses to
evaluate the effect of BITC on FOXO1 translocation. HepG2 cells were selected to evaluate the
effect of BITC on gene and protein expression including liver specific gluconeogenic gene
expression. HepG2 were cultivated in EMEMwith 1g glucose/L, low level like under conditions
of starvation before a meal in humans; stable glutamine; 2.2 g NaHCO3, supplemented with
1% NEAA (Non-Essential Amino acids) and 10% Fetal calf serum (FCS). U-2 OS were grown
in DMEMwith 4.5 g glucose/L like after a meal (for better growth); 3.7 g/L NaHCO3; stable
glutamine and Na-pyruvate supplemented with 10% FCS.Media were proposed by ECACC
(European Animal and Cell Collection) for cell cultivation.
U-2 OS were transfected with DNA plasmids using Lipofectamine 2000 in Opti-MEM1 I
Reduced-SerumMedium (Invitrogen) according to the manufacturer´s description. A stable
transfection of U-2 OS for constitutive expression of green fluorescent protein (GFP) labelled
FOXO1 was obtained using pEGFP-N1 as vector, with an insertion of FOXO1 cDNA (com-
plete FOXO1 coding sequence (CDS) in front of the CDS of EGFP. The vector used for the
transfectionwas a gift as courtesy from Terry Unterman (University of Illinois at Chicago,
USA) [30].
Following transfection, cells were grown in DMEM plus 10% FCS. GeneticinG418 sulfate
(Calbiochem) at 0.4 mg/ml was added after 48h, for selecting those genetically engineered cells
carrying the plasmid with encoded resistance. Separating cells over 3 passages resulted in
homogeneous cell colonies expressing FOXO1-GFP, monitored by fluorescencemicroscopic
live cell imaging [15]. Prior cell incubation with test compounds, growth of sub-confluent U-2
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OS cells was controlled for 16 h by an initial reduction from 10% FCS to 2% FCS, and further
to 0% FCS in DMEM for 1h starvation.
For transfection of silencing RNA (siRNA) into HepG2 cells, combined DharmaFECT4
(D4) transfection reagent and siRNAs ON-TARGETplus SMARTpool siRNA (Dharmacon)
were applied. SMARTpool siRNA contained four SMARTselection-designed siRNAs, pooled
for efficient knock-down of each analyzed target: FOXO1, AKT, SIRT1, NRF2, and NON-Tar-
get siRNAs NT were used for control transfections according to the description of the manu-
facturer. Prior to cell incubation with test compounds HepG2 cells were starved for 16 h in
EMEMwith 1 g/L glucose without FCS. Stimulation of cells was performedwith benzyl gluco-
sinolate dissolved in FCS-freemedium and treated with 100 μg myrosinase at 37°C during 15
min enabling the formation of BITC. Insulin stimulations were performedwith 100 nM
human insulin in FCS-freemedium.
Quantificationof gene expression by qRT-PCR
Total RNA was extracted upon 24 h incubationwith BITC and insulin, using the Nucleospin RNA
II total isolation kit (Machery-Nagel). RNA purity and quantity were assessed using the NanoDrop
2000 UV/VIS spectrophotometer (Thermo Scientific).High-capacity cDNA RT-PCR Kit (Applied
Biosystems) was used to reverse transcribe 1 μg of RNA. For quantitative real-time PCR (qRT),
samples were diluted in DNase/RNase freewater. A final volume of 5 μl (1 μl cDNA corresponding
to 100 ng of total RNA), 2 μl SYBR1 Green PCRMaster Mix (Applied Biosystems), 300 nmol/L
forward and reverse primer see Table 1. and 1.3 μl RNase/DNase freeWater for each reactionwas
used. The measurement was performedwith ViiA7 Real-Time PCR System (Life Technologies)
with the following thermal cycler conditions: 10 min at 95°C followed by 40 alternated cycles of 15
sec at 95°C and 35 sec at 60°C. For melting curve analysis, the reactions were heated to 95°C for 15
sec, cooled down to 60°C for 15 sec and heated again to 95°C for 15 sec. Reactionswere carried out
in triplicates. The ribosomal protein L32 (RPL32) housekeeping gene was used for normalization
as an endogenous control. The mean value was used for further calculations. Reported levels of
mRNA are expressed as fold changes and compared to untreated control cells.
Protein extraction andWestern blotting
Upon incubation with the compounds cells were lysed with lysis buffer (Cell Signaling Tech-
nology) supplemented with protease- and phosphatase-inhibitors (Roche). Each 20 μg of pro-
tein were denaturated in SDS-PAGE sample buffer at 95°C for 5 min and subsequently
separated by sodium dodecyl sulfate (SDS)-polyacrylamidegel electrophoresis (PAGE). Sepa-
rated proteins were transferred onto PVDF- nitrocellulosemembranes (Immobilon-FL;Milli-
pore) and analyzed for the presence of Phospho-FOXO1(Thr24)/FOXO3a (Thr32) and
PEPCK (PCK2) with primary antibodies from Cell Signaling Technology and G6Pase-antibod-
ies from Santa Cruz Biotechnology. For normalization alpha-Tubulin or Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) antibodies from Cell Signaling Technology were used.
Detectionwas performedwith fluorescent secondary antibodies (LI-COR Biosciences for ODI-
SEY) via the Odyssey Imaging System (Licor, Lincoln, NA).
Path scan intracellular signaling array
A PathScan Signaling Array Kit (Cell Signaling Technology) with a fluorescent readout for the
simultaneous detection of the phosphorylated signalingmolecules protein kinase B: AKT
(Thr308), AKT (Ser473), extracellular-signal-regulated kinase ERK1/2 (Thr202/Tyr204), and
stress-activated kinases/c-JunN-terminal kinase SAPK/JNK (Thr183/Tyr185) was used
according to the manufacturer’s instructions. Cell lysates were obtained from HepG2 treated
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with BITC 30 μM, insulin 100 nM and insulin plus BITC for 30 min. Upon sonication and cen-
trifugation, the clear supernatant was used for protein content determination. LI-COR Biolu-
minescence imager and ODYSSEY software were used for scans and analyses.
Cell viability assay
The viability of HepG2 cells after 24 h incubation with selected BITC concentrations of 1 μM,
2 μM, 5 μM, 10 μM, 20 μM, 50 μM, and 100 μM was tested with the CellTiter96 Aqueous Cell
Proliferation assay (Promega) according to the manufacturer’s instructions. The U-2 OS cells
survival after BITC stimulation was observedduring microscopic life cell imaging.
FOXO-translocation assay
Stably transfectedU-2 OS cells with pEGFP-FOXO1 expressing FOXO1 with C-terminal tagged
GFP were used for FOXO1-GFP visualization by fluorescencemicroscopy with Zeiss “Axio
Observer.Z1” inverted fluorescent microscope in black, clear bottom 96-well plates with poly-D-
lysine coating (Becton,Dickinson and Company, USA). Life cell images were recorded every
minute up to 1 h with a filter for GFP, for tracing intracellular translocation of FOXO1-GFP after
cells treatment with: a) insulin 100 nM; b) BITC 30 to 100 μM; c) insulin + BITC; d) NAC (N-
acetyl cysteine); e) BITC + NAC; f) insulin + NAC and g) BITC + insulin + NAC.
Staining with 4´,6-diamidino-2-paraphenylindole (DAPI) 200 nM (Invitrogen) was used
for defining nuclear areas. Fluorescencemicroscopic UV-Exposition was performed in BD
Pathway 435 Bioimager (BectonDickinson and Company). Quantification of GFP signals in
nuclear areas and cytoplasmwas analyzed using BD AttoVision version 1.6/435. Ratios of
GFP_nuclear intensity and GFP_cytoplasmic intensity as Ratio Nuc/Cyt were established.
Ratios lower than 1 reflected a predominant cytoplasmic localization of FOXO1-GFP, while
higher than 1 showed a nuclear accumulation of FOXO1. An induced translocation factor
could be calculated after substance treatment by normalization versus untreated cells.
Purificationof glucosinolates for cell culture test systems and
glucosinolate analysis
The benzyl glucosinolate was extracted from seeds of Tropaeolum majus (nasturtium) accord-
ing to the method described in Lippmann et al. for aliphatic and aromatic glucosinolates [31].
Benzylglucosinolatewas converted to benzylisothiocyanate after 15 minutes treatment with
Table 1. Primer sequences for qRT-PCR.
Target Oligo name Oligo sequence (5' to 3') Fwd Oligo sequence (5' to 3') Rev
60S ribosomal protein L32 hRLP-32 CAACGTCAAGGAGCTGGAAGT TTGTGAGCGATCTCGGCAC
Forkhead box O1 hFOXO1 GGCTGGAAGAATTCAATTCGTC ACCCTCTGGATTGAGCATCCAC
Glucose-6-phosphatase hG6Pc CCCCTGATAAAGCAGTTCCCT ATACACCTGCTGTGCCCATG
nuclear factor (erythroidderived)-like2 hNRF2 AACTACTCCCAGGTTGCCCA CAAGTGACTGAAACGTAGCCGA
Phosphoenolpyruvat-carboxykinase hPEPCK AAGTATGACAACTGCTGGTTGGC ATAACCGTCTTGCTTTCGATCCT
Proteinkinase B hAKT1 GCTTCTATGGCGCTGAGATTGT TGATCTTAATGTGCCCGTCCTT
NAD-dependent deacetylase sirtuin-1 (Sirtuin1) hSIRT1 ATGCTGGCCTAATAGAGTGGCA CCTCAGCGCCATGGAAAAT
Catalase hCAT GCGGTCAAGAACTTCACTGAGG GGTGTGAATCGCATTCTTAGGC
Glutathione peroxidase 2 hGPX-2 GTGCTGATTGAGAATGTGGC AGGATGCTCGTTCTGCCCA
NAD(P)H dehydrogenase (quinone 1) hNQO1 CATCACAGGTAAACTGAAGGACCC CTCTGGAATATCACAAGGTCTGCG
Sulfiredoxin-1 hSRXN1 CTCAGTGCTCGTTACTTCATGGTC GTTTGGCCCTTCCTCTTCCTCC
Superoxide dismutase hSOD2 GCCTGCACTGAAGTTCAATGG CGTTTGATGGCTTCCAGCA
doi:10.1371/journal.pone.0162397.t001
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myrosinase (from Sinapis alba seed EC 3.2.1.147, purchased from Sigma-AldrichChemie
GmbH). BITC recovery was more than 95% as deduced by Gas chromatography–mass spec-
trometry (GC-MS), while benzylglucosinolate could not be detected in High-performance liq-
uid chromatography (HPLC) after 15 minutes incubation.
Data handling and statistical analyses
One-way ANOVA with appropriate post hoc tests (Bonferroni and Dunnett’s Multiple Com-
parison post-hoc test) or 2-tailed unpaired t Test were used for statistical analysis using SPSS.
Values of p 0.05 were assumed to be significant. All results are presented as means ± SEM.
The half maximal effective concentrations EC50 and median inhibitory concentration IC50
values were calculated using GraphPad Prism 5.0 software (San Diego, CA, USA).
Results
BITC induces FOXO1 translocation in U-2 OS stably transfected with
pEGFP-FOXO1
After treatment with BITC at concentrations of 1, 10 and 100 μM for 1 h translocation of
FOXO1 was induced in stably transfectedU-2 OS-FOXO1-GFP cell cultures in a dose depen-
dent manner (Fig 1A–1D). Unstimulated cells showed FOXO1-GFP predominantly localized
in the cytoplasm (Fig 1A).
A significant FOXO1 nuclear accumulation with increasing BITC concentration was
observed (Fig 2). A slight increase up to 1.14-fold was observed for BITC concentrations below
10 μM, becoming progressively more significant (up to 3.59-fold) for concentrations between
10 μM and 50 μM. Further increase in BITC concentration did not modify nuclear accumula-
tion of FOXO1. Time-dependent FOXO1 translocation was also observedby life cell imaging
of U-2 OS FOXO1-GFP in living cells during incubation for 1 h with BITC 50 μM. In control
cells FOXO1 was located in cytoplasm but with increasing concentrations FOXO1 migrated to
the nuclei (S1 Video).
The BITC dose dependencywas evaluated in the range 1 μM to 100 μM during 1h and the
reversibility of FOXO1 translocation into nuclei was tested by adding 100 nM insulin for 30
min into parallel cell cultures (Fig 3). Insulin 100 nM applied 30 min after BITC partially
reversed FOXO1 translocation induced by BITC 10 μM to 100 μM, which was significant for
the doses 20 to 100 μM. The half maximal effective concentrations (EC50) values were 29.4 μM
and 33 μM for BITC and BITC + insulin, respectively. A competition between nuclear import
by BITC and export by insulin can be deduced from these data.
FOXO1 translocation from cytoplasm into the nucleus is inhibited by the
antioxidant N-acetyl-cystein (NAC)
We investigated whether the generation of intracellular oxidative stress is part of the mecha-
nism by which BITC induces FOXO1 translocation and activation (Fig 4). Upon BITC treat-
ment or BITC + insulin FOXO1 translocated to the nucleus, as previously was shown in the
first translocation analysis. By contrast, when BITC was incubated in combination with N-ace-
tyl-L-cystein (NAC) or insulin plus NAC, FOXO1 translocation into the nucleus was inhibited.
Cell viability
The survival rates of insulin sensitive HepG2 cells expressing endogenous FOXO1 up to 50 μM
BITC were not affected (Fig 5). A significant reduction of about 34% cell viability was found
after 24 h for 100 μM BITC, but not for 100 μM benzyl glucosinolate. Survival of U-2
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OS-FOXO1-GFP cells after the stimulation with concentrations up to 100 μM BITC was not
affected, as is observed in Fig 1A–1D.
BITC down-regulates the gene expression of G6Pase and PEPCK
BITC reducedmarkedly the gene expression of PEPCK and G6Pase in a dose dependent man-
ner. For instance, during 24 h treatment with concentrations from 0.5 μM to 20 μM BITC,
PEPCKmRNA was down-regulated significantly to 0.28-fold expression, which means
3.57-fold reduction (Fig 6). However, this effect became less pronounced and lost significance
for concentrations between 30 μM and 50 μM BITC. A dose dependent reduction in the gene
expression of G6Pase (significant for 20 μM and 50 μM) was achieved with 0.1 μM to 50 μM
BITC (to 0.24-fold expression or 4.17-fold reduction with 20 μM (Fig 7). The effect of 30 μM
BITC on the gene expression of both enzymes was continuously monitored from 2 h to 24 h
(Figs 8 and 9). For PEPCK, significant differences were obtained after 2 h and 6 h (p = 0.02 and
p = 0.01, respectively). For G6pase the reduction was observed from 6 h to 24 h stimulation
and reached significance at 24 h (p = 0.01). The median inhibitory dose of BITC (IC50) was
determined for both PEPCK (IC50 = 3.7 μM) and G6Pase (IC50 = 3.4 μM).
BITCmodulates the gene expression of antioxidant enzymes
BITC induced a dose-dependent down-regulation of catalase (CAT) with a significant reduc-
tion (around 50%) for concentrations higher than 10 μM (Fig 10). Conversely, manganese
Fig 1. FOXO1 translocation in stably transfectedU-2 OS (humanosteosarcoma cells).Fig 1A–1D show
FOXO1-GFP expressing cells and nuclear DAPI-staining (red) changing to orange-yellow in overlays with
GFP after incubation with BITC at concentrations of 0 (1A-A’), 1 (1B-B’), 10 (1C-C’) and 100 μM (1D-D’),
respectively. Following 1 h of starvation, stimulation of cells was performedwith BITC for 1 h. Cells were fixed
and stainedwith DAPI for identification of nuclear areas by fluorescence microscopic detection, for
segmentation of cells and calculation of GFP-intensity ratios in nuclei and cytoplasm (Nuc/Cyt).
doi:10.1371/journal.pone.0162397.g001
Fig 2. U-2 OS-FOXO1-GFP cells treatedwithBITC at selectedconcentrations.Nuclear accumulation was estimated
by measuring the ratio of FOXO1 nuclear/FOXO1 cytosolic (FOXO1 Nuc/Cyt) after 1 h treatment normalized to untreated
control cells. Ratios higher than 1 showed a nuclear accumulation of FOXO1. Results are presented as mean values
+ standard error (SEM) (n = 4). Significant differences vs control (0 μM) are labelled for *(p<0.05) and **(p<0.01)
(Oneway ANOVA and posthoc Bonferroni multiple comparisons).
doi:10.1371/journal.pone.0162397.g002
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superoxide dismutase (MnSOD) gene expression was significantly reducedwith low concentra-
tions but increased from 10 μM BITC on, reaching a 2.5-fold maximum at 50 μM (Fig 11).
Fig 3. U-2 OS-FOXO1-GFP cells treatedwithBITC 1–100 μM for 1h and additionof 100 nM insulin after
30min. The curves show the relative nuclei/cytoplasm intensity of FOXO1-GFP for BITCwithout (black
curve) and with insulin addition (red curve). Results are presented as mean values + standard error (SEM)
(n = 4). Significant differences vs control (0 μM) are labelled for *(p<0.05) and **(p<0.01) (Oneway ANOVA
and posthocDunnett T3).
doi:10.1371/journal.pone.0162397.g003
Fig 4. Inhibition of U 2-OS-FOXO1-GFP cells translocation upon antioxidant protection.Stimulationwith insulin 100 nM, BITC 30 μM, insulin
+ BITC, NAC 5mM (N acetyl cysteine), BITC + NAC, insulin + NAC and BITC + insulin + NAC for 2 h. Data shown as mean ± SEM (n = 4)
normalized to untreated control cells. **(p<0.01) vs BITC 30 μM (Oneway ANOVA and posthoc Dunnett T3).
doi:10.1371/journal.pone.0162397.g004
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More interestingly, time-dependent analyses showed that this effect just started after 16 h for
both enzymes and persists up to after 24 h of incubation (Figs 12 and 13). Detoxification path-
ways were analyzed through gene expression analyses of nuclear factor (erythroid derived)-
like2 (NRF2), Sulfiredoxin-1 (SRXN1), NAD(P)H dehydrogenase [quinone] 1 (NQO1) and
Glutathione peroxidase 2 (GPX-2). HepG2 cells were treated with 30 μM BITC for 24 h and
Fig 5. HepG2 cells survival.Following 4 h incubation at 37°Cwith 20 μMof PMS-electron coupling reagent (3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy phenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS)/
phenazinemethosulfate, the optical density (OD) of the MTS bioreductionproduct formazan was measured at
490 nmwavelength. ODmean values were normalized to mock treated cells (100% survival).Mean values
+ SEM (n = 3) *(p<0.05) significant differences vs control (Oneway ANOVA and posthoc Bonferroni).
doi:10.1371/journal.pone.0162397.g005
Fig 6. PEPCK gene expression in HepG2 cellsmodulatedby BITC. The gene expression at selected
BITC concentrations (0.1 μM to 50 μMpresented in logarithmic scale) is shown for PEPCK. Fold mRNA
expression was normalized to the housekeeping gene RPL32 and control (0 μMBITC), the control value is
unity. One way ANOVA was used for the nonlinear regression.Data shown as mean value ± SEM of gene
expression versus control *(p<0.05) and **(p<0.01).
doi:10.1371/journal.pone.0162397.g006
Benzylglucosinolate and Gluconeogenic Gene and Protein Expression
PLOSONE | DOI:10.1371/journal.pone.0162397 September 13, 2016 10 / 27
mRNA was extracted for qRT-PCR analyses. Although NRF2 is not influenced by the presence
of BITC, the detoxification enzymes SRXN1 and NQO1 have shown a significant increase of
2.9- and 1.19-fold, respectively (S1 Fig).
Fig 7. G6Pase gene expression in HepG2 cellsmodulated by BITC.The gene expression at selected
BITC concentrations (0.1 μM to 50 μMpresented in logarithmic scale) is shown for G6Pase. Fold mRNA
expression was normalized to the housekeeping gene RPL32 and control (0 μM), the control value is unity.
One way ANOVA was used for the nonlinear regression. Data shown as mean value + SEM of gene
expression versus control *(p<0.05).
doi:10.1371/journal.pone.0162397.g007
Fig 8. PEPCK time dependency analyses in HepG2 cellsmodulatedby BITC. Time dependency
analyses upon stimulation with BITC 30 μM is shown for PEPCK. Fold mRNA expression was normalized to
the housekeeping gene RPL32 and control (0 hours), the control value is unity. One way ANOVA was used
for the nonlinear regression analyses. Data shown as mean value ± SEM of gene expression versus control *
(p<0.05).
doi:10.1371/journal.pone.0162397.g008
Benzylglucosinolate and Gluconeogenic Gene and Protein Expression
PLOSONE | DOI:10.1371/journal.pone.0162397 September 13, 2016 11 / 27
G6Pase and PEPCK gene expression upon FOXO1, AKT, NRF2 and
SIRT1 siRNA knock-down
In order to find an explanation of the underlyingmechanisms for the modulation of gene
expression by BITC, the transcription factors FOXO1 and NRF2, and modulators such as AKT
and SIRT1 were knocked-down and the gluconeogenic gene expression was evaluated.
Table 2 summarizes the gene expression under FOXO1, AKT, SIRT1, NRF2 knock-down
conditions. FOXO1 was efficiently knocked-downby 45% (p = 0.003) upon FOXO1-specific
siRNA for 48 h, and its gene expression was not significantly affected by siRNA against the
other factors. AKT was significantly reduced (72%, p<0.001) upon AKT siRNA treatment, and
AKT basal gene expression was FOXO1, SIRT1 and NRF2 independent. Upon the siRNA treat-
ment SIRT1 was successfully reduced by 43% (p = 0.001), and significantly increased upon
FOXO1 and AKT knock-down 131% and 32%, respectively (p = 0.019 and p = 0.015, respec-
tively). NRF2 was knocked-downby NFR2 siRNA 40% (p = 0.05) and not affected by FOXO1-,
AKT- and SIRT1-siRNAs. None of the factors knock-down had significant effects on PEPCK
gene expression (Fig 14), although under AKT knock-down a non-significant increase of
PEPCKmRNA was observed indicating a higher expression rate under reduced AKT leading
to lower phosphorylating capacity for inactivation of FOXO1. G6Pase mRNA was reduced by
55% upon FOXO1 knock-down (p = 0.007, Fig 15), which confirms the role of FOXO1 in regu-
lating G6Pase gene expression. Upon BITC treatment for 24 h, G6Pase mRNA was signifi-
cantly down-regulated 35% in control cells (p<0.05) and 62% upon FOXO1 knock-down
(p<0.05) compared to cells without siRNA treatment and stimulated with BITC. In the last
case the significance reached by BITC compared to the unstimulated cells was reduced to less
Fig 9. G6Pase time dependencyanalyses in HepG2 cellsmodulated by BITC.Time dependency
analyses upon stimulation with BITC 30 μM is shown for G6Pase. Fold mRNA expression was normalized to
the housekeeping gene RPL32 and control (0 hours), the control value is unity. One way ANOVA was used
for the nonlinear regression analyses. Data shown as mean value ± SEM of gene expression versus control *
(p<0.05).
doi:10.1371/journal.pone.0162397.g009
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than half of the expression rate achieved under FOXO1 knock-down.An increasing trend in
PEPCK and G6Pase basal gene expression upon NRF2 knock-downwas observed, and after
BITC stimuli the down-regulation of G6Pase mRNA was abolished compared to cells without
siRNA treatment and stimulated with BITC.
Effect of BITC on phosphorylationand protein expression
i) AKT- and FOXO1 phosphorylation. Path scan analyses were performed to elucidate
the mechanisms, as post-translational modifications, by which BITCmodulates FOXO1 trans-
location and activation. As expected, incubation with insulin 100 nM increasedAKT phos-
phorylation, which was no reversed by BITC for Ser473 and for Thr308 (Fig 16) when BITC
was incubated after insulin stimuli. Treatment of HepG2 cells with 30 μM BITC for 30 min
induced a significant reduction in the phosphorylation of AKT at Ser473 (Fig 17). Western blot
analyses evaluating FOXO1 phosphorylation following a pre-incubation with 30 μM BITC for
24 h showed a significant reduction in pFOXO1 as compared to untreated cells (Fig 18).
ii) MAPKs protein phosphorylation. Although not significant, BITC increased ERK 1/2
phosphorylation 1.5 fold (Fig 19), as compared with control cells. BITC also induced by>2 fold
the phosphorylationwhen cells where stimulated in combination with insulin (p = 0.02). JNK
phosphorylationwas significant increased 2.13 fold after the stimulation with BITC (Fig 20).
BITC reversed the inhibitory effect of insulin on JNK phosphorylationwhen the cells where
treated with insulin and BITC together, in comparison with cells treated only with insulin.
iii) Gluconeogenic proteins. A significant reduction in PEPCK and G6Pase protein
expression occurred after treatment with BITC p<0.001 and p<0.01 respectively (Fig 21). The
results are in agreement to those observed in the gene expression analyses (Figs 6 and 7).
Fig 10. CAT gene expression in HepG2 cellsmodulated by BITC.Dose-dependency is shown for the
antioxidant enzymeCAT. Results are presented as fold mRNA expression, normalized to the housekeeping
gene RPL32 and the control. Data shown as mean value ± SEM *(p<0.05), **(p<0.01) and ***(p<0.001).
(Oneway ANOVA and posthoc Bonferroni).
doi:10.1371/journal.pone.0162397.g010
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Discussion
This work has shown that in U-2 OS cells stably expressing FOXO1-GFP BITC is able to pro-
mote FOXO1 nuclear accumulation in a dose dependent manner preventing FOXO1 degrada-
tion in the cytoplasm. These results are supported by previous studies from Boreddy et al. who
showed an increased FOXO1 nuclear accumulation and FOXO1 dependent transcription upon
BITC stimulation by immunofluorescence analysis in pancreatic cells [32]. In contrast, in our
study FOXO1 translocation was completely inhibited in U-2 OS cells pretreated with the anti-
oxidant NAC, suggesting that induction of oxidative stress by BITCs is required for the
FOXO1 translocation, as also shown for lung cancer cells [33]. However, Zhang indicates that
NAC stimulation might block the uptake of BITC in murine hepatoma cells [34]. It is possible
that in our work the observedNAC effect of cytoplasmic retention of FOXO1 may, in part, be
due to an inhibition of BITC uptake.
The oxidative stress induction and its effect on FOXO1 nuclear import and accumulation
have been demonstrated by other phytochemicals. Recent studies show that resveratrol behave
as a pro-oxidizing agent [35] exerting its favourable biological effects through the induction of
intracellular reactive oxygen species, promoting FOXO1 nuclear import and activation, which
induce the transcription of factors involved in antioxidant pathways [11]. Thus the activation
of FOXO1 induces cellular protective pathways such as oxidative stress resistance, apoptosis
and autophagy [36, 37]. Although, in T2D oxidative stress is currently considered to play a role
in diabeticmicro- and macrovascular complications, the induction of antioxidative mecha-
nisms might improve the cellular defense, depending on the pro- and antioxidative redox bal-
ance. It is important to highlight that although the FOXO1 nuclear import, FOXO1
Fig 11. MnSODgene expression in HepG2 cellsmodulatedby BITC.Dose-dependency is shown for the
antioxidant enzymeSOD. Results are presentedas fold mRNA expression, normalized to the housekeeping
gene RPL32 and the control. Data shown as mean value ± SEM *(p<0.05). (Oneway ANOVA and posthoc
Bonferroni).
doi:10.1371/journal.pone.0162397.g011
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accumulation and SIRT1 gene expression induction observed in the present study are critical
steps in FOXO1 transcription induction, it was not evaluated in the current study.
FOXO1 nuclear accumulation could additionally be the result of a reduction of its phos-
phorylation by AKT (the main pathway of FOXO nuclear exclusion and degradation following
insulin or IGF signaling) or by ERK [38]; dephosphorylation by protein phosphatases [39]; or
additional post-translational modifications such as phosphorylation by JNK [40], p38 [41] or
cyclin dependent kinase 1 (CDK1) [42], which have been described as inducers of FOXO1
nuclear accumulation in response to oxidative stress and other stimuli [10, 43].
Insulin was able to antagonize the effect of BITC, since incubation with BITC in combina-
tion with insulin induced FOXO1 accumulation. Since FOXO1 protein was located in the cyto-
plasm and migrated into the nucleus upon BITC stimulation, a reduced level of pFOXO1 was
expected after BITC stimulus. The effect of 30 μM BITC on pFOXO1 levels was evaluated by
stimulating the cells for 24 h similar to the procedure used for the gene expression analyses,
and a significant reduction of pFOXO1 was observed.The reduction in FOXO phosphorylation
upon isothiocyanates stimulation has been shown previously by Boreddy et al. in mice pancre-
atic cancer cells [32] and by Davis et al. in human umbilical vein endothelial cells [44].
The reduction in pAKT (Ser473) by BITC (Fig 17) confirms the role of the AKT pathway in
the regulation of FOXO1 translocation upon the BITC stimulus shown by others previously
[32]. The MAPK, ERK, and JNK proteins activated by stress stimuli [45, 46], were evaluated to
address additional mechanisms involved in the FOXO1 activation. JNK, which has up-regu-
lated significantly in the present study, is responsible for FOXO1 modulation [41, 47]. JNK
induces FOXO1 nuclear import enhancing the glucose production in hepatitis C virus-infected
cells [40] or enhancing angiogenesis in fibroblasts [41]. ERK in contrast promotes FOXO1
nuclear export [41], by phosphorylation in nine serine residues, different from those three
Fig 12. CAT time dependencyanalyses in HepG2 cellsmodulated by BITC.Time dependent analyses
for CAT. Results are presented as fold mRNA expression, normalized to the housekeeping gene RPL32 and
the control. Data shown as mean value ± SEM *(p<0.05). (Oneway ANOVA and posthoc Bonferroni).
doi:10.1371/journal.pone.0162397.g012
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residues that can be phosphorylated by AKT which were not evaluated in this study [13]. The
FOXO1 translocation and nuclear accumulation observed in the current study suggests a prob-
able inducing effect by JNK.We could assume that the non-significant increase in ERK phos-
phorylation could be linked to the inhibition in gluconeogenesis found in this work. Previous
studies have reported that activation of the MAPK/ERK pathway can also inhibit the expres-
sion of PEPCK and G6Pase genes, most likely through a mechanism independent from insulin
[13]. The inducer effect of ITCs on MAPKs has also been demonstrated previously in the pre-
vention of cancer in other studies [46].
Fig 13. SOD time dependency analyses in HepG2 cellsmodulated by BITC. Time dependent analyses for
SOD. Results are presented as fold mRNA expression, normalized to the housekeeping gene RPL32 and the
control. Data shown as mean value ± SEM *(p<0.05). (Oneway ANOVA and posthoc Bonferroni).
doi:10.1371/journal.pone.0162397.g013
Table 2. Gene expression changes (%) after FOXO1, AKT, SIRT1 andNRF2 knock-down.
si RNAs Treatment FOXO1 mRNA Levels AKTmRNA Levels SIRT1mRNALevels NRF2mRNALevels
Control (NT) 100 100 100 100
FOXO1 **-45,30 +27,33 *+131,81 +155,80
AKT -4,72 ***-71,90 *+32,58 +67,45
SIRT1 +33,19 +27,12 ***-42,71 +96,21
NRF2 +37,45 +25,58 +64,24 *-39,77
48 h after transfection of HepG2 cells, including a starvation period of 16 h in EMEMwithout FBS, RNA was extracted, reverse transcribedand qRT-PCR
performed with primers given in Table 1. Quantified relative amplification vs housekeeping gene RPL32 expression was normalized to the rate in HepG2
transfected with non-targetNT siRNA (100% rate of expression). MeanmRNA levels (n 4) are shown as percentage of change of basal expression
regarding to the transfection controls. The knock-down efficiencies for each factor are shown in grey. The statistical significance level was set at p<0.05
(Unpaired Student’s t test). *p<0.05, **p<0.01 and ***p<0.001 vs control cells transfected with Non Target siRNA (NT) normalized with RPL32 and control.
doi:10.1371/journal.pone.0162397.t002
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FOXO transcription factors regulate gene expression positively and negatively [12]. Previ-
ous studies provide evidence that in the absence of insulin stimulation or in the fasting state,
FOXO1 induces glucose production through the induction of G6ase and PEPCK gene expres-
sion [48]. In this study BITC induces a dose dependent down-regulation of gluconeogenesis, as
confirmed by the reduction in PEPCK and G6Pase gene and protein expression. BITC reduced
PEPCKmRNA within the first 6 h of stimulation (early phase of gluconeogenesis),while
G6Pase was down-regulated from 6 h to 24 h (late phase of gluconeogenesis), revealing BITC
to act as an inhibitor of gluconeogenesis. This could be considered as a positive factor in T2D
prevention or treatment, since increased hepatic glucose production is a major feature of the
disease [49] and an inhibition of gluconeogenesis could improve directly or indirectly insulin
Fig 14. HepG2 cells siRNA knock-down analyses and PEPCK gene expression.BITC 30 μM influence
after starvationon PEPCK gene expression upon FOXO1, AKT, NRF2 and SIRT knock-down conditions.
(Unpaired Student’s t test) vs control cells treatedwith NT or NT+BITC, normalizedwith RPL32. Data shown
as mean of fold mRNA+ SEM (n = 4).
doi:10.1371/journal.pone.0162397.g014
Fig 15. HepG2 cells siRNA knock-down analyses andG6Pase gene expression.BITC 30 μM influence
after starvationon G6Pase gene expression upon FOXO1, AKT, NRF2 and SIRT knock-down conditions.
*p<0.05, **p<0.01 (Unpaired Student’s t test) vs control cells treatedwith NT “*”or NT+BITC “#”, normalized
with RPL32. Data shown as mean of fold mRNA + SEM (n = 4).
doi:10.1371/journal.pone.0162397.g015
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signaling and sensitivity. Our suggestion is supported byWaterman C et al. who found a reduc-
tion in gluconeogenic enzymes gene expression in liver of mice fed with very high fat diet sup-
plemented with moringa benzyl isothiocyanate [25]. In vivo studies in humans support also
our results, Bahadoran et al. showed a significant reduction in fasting glucose and insulin resis-
tance after a 4-week-treatment of type 2 diabetic patients with 5 and 10 g/d broccoli sprouts
powder containing mainly 4-methylsulfinylbutyl glucosinolate [50].
In agreement with the siRNA analyses, the BITC effect on gluconeogenic genes is indepen-
dent from all the factors knocked-down.Despite not significant higher expression of PEPCK
was observedunder reduced AKT. Less AKT can be responsible for reduced FOXO1-pho-
sphorylation under AKT siRNA conditions, which could further induce PEPCK gene
Fig 16. AKT (Thr308) phosphorylation uponBITC and insulin treatment.HepG2 cells were incubated
with BITC 30 μM, insulin 100 nM and insulin + BITC for 30 min. PathScan Signaling Array Kit was used for the
detection of the phosphorylatedAKT (Thr308).Data shown as mean of fold phosphorylation normalized to
untreated control + SEM (n = 3) *p<0.05(UnpairedStudent’s t test).
doi:10.1371/journal.pone.0162397.g016
Fig 17. AKT (Ser473) phosphorylation uponBITC and insulin treatment.HepG2 cells were incubated
with BITC 30 μM, insulin 100 nM and insulin + BITC for 30 min. PathScan Signaling Array Kit was used for the
detection of the phosphorylatedAKT (Ser473).Data shown as mean of fold phosphorylationnormalized to
untreated control + SEM (n = 3) *p<0.05, **p<0.01 (Unpaired Student’s t test).
doi:10.1371/journal.pone.0162397.g017
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Fig 18. FOXO1 phosphorylationuponBITC treatment.HepG2 cells were incubatedwith 30 μMBITC for
24 h and cell lysates were preparedand subjected toWestern blot analysis with antibodies for pFOXO1
Thr24 (Phospho FOXO1). Total FOXO1 was used for normalization. Data shown as mean + SEM (n = 3)
***p<0.001 (UnpairedStudent’s t test).
doi:10.1371/journal.pone.0162397.g018
Fig 19. ERK phosphorylation uponBITC and insulin treatment.HepG2 cells were incubatedwith BITC
30 μM, insulin 100 nM and insulin + BITC for 30 min. PathScan Signaling Array Kit was used for the detection
of the phosphorylatedmolecule ERK1/2(Thr202/Tyr204). Data shown as + SEM (n = 3) * p<0.05, **p<0.01
(Unpaired Student’s t test).
doi:10.1371/journal.pone.0162397.g019
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expression; however, this effect was not disturbed by BITC in the present study. Compared to
NT-siRNA treatment, FOXO1 modulation of G6Pase expression is demonstrated by the reduc-
tion of G6Pase after FOXO1-siRNA. The significant down-regulation by BITC could be con-
sidered FOXO1-independent, as the significance in FOXO1-siRNA treated cells is not lost.
Only NRF2 seems to be necessary for the effect of BITC-inducedG6Pase-reduction, as the sig-
nificant inhibitory effect of BITC on G6Pase was abolished after NRF2-siRNA knockdown at a
higher level of G6Pase expression compared to NT-siRNA treatment. Recent promoter analysis
Fig 20. JNK phosphorylation uponBITC and insulin treatment.HepG2 cells were incubatedwith BITC
30 μM, insulin 100 nM and insulin + BITC for 30 min. PathScan Signaling Array Kit was used for the detection
of the phosphorylatedmolecule SAPK/JNK (Thr183/Tyr185). Data shown as + SEM (n = 3) * p<0.05
(Unpaired Student’s t test).
doi:10.1371/journal.pone.0162397.g020
Fig 21. Gluconeogenic enzymes protein expression.HepG2 cells were incubatedwith 30 μMBITC for 24
h and cell lysates were prepared and subjected toWestern immuno-blot analysis with primaryantibodies for
PEPCK and G6Pase. Results are normalizedwith GAPDH. Data shown as + SEM (n = 3) **p<0.01,
***p<0.001 (UnpairedStudent’s t test).
doi:10.1371/journal.pone.0162397.g021
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of human PEPCK performed by our group showed 10 binding motifs for NRF2, one of them
near to the transcription start site close to the FOXO1-binding site IRE2 [15]. Aleksunes et al.
showed an increase in G6Pase gene expression in Nrf2-null mice, indicating that Nrf2 influ-
ences the transcriptional regulation of gluconeogenic genes [51]. The potential NRF2 effect on
gluconeogenesis regulation is supported by Slocum et al., which recently showed that increased
Keap1/Nrf2 signaling in the liver of hypomorphic Keap1 allele mice is accompanied by
repressed gluconeogenesis,measured by a reduction in PEPCK and G6Pase gene expression
[52].
It is noteworthy that PEPCK and G6Pase are regulated both directly and indirectly via tran-
scriptional and posttranscriptionalmechanisms in a network type manner [53], which can
mutually compensate their functions in the absence or reduction of each single factor, making
it difficult to determine the relative contribution of individual transcription factors to these
processes [54]. These results suggested that the AKT-FOXO1 cascademight not be the only
driver of the transition from fasting to feedingmetabolic states [55]. FOXO1 transcriptional
activity has been related to the late phase of gluconeogenesis [56], were it interacts with other
transcription factors such as PGC-1α, ERRγ and HNF4 inducing G6Pase and PEPCK gene
expression [48]. In the current study the BITC dependent down-regulation in PEPCK and
G6Pase was observedwithin the first 6 h and up to 24 h, respectively, which suggests that addi-
tional factors different from FOXO1 could be involved in the gluconeogenic response to BITC.
Recently, FOXO6 was also found to be involved in gluconeogenesis [57], suggesting that in the
control of hepatic gluconeogenesis in vivo some redundancymight be present among FOXO
transcription factors [48]. The progression and complications of diabetes are linked to oxida-
tive stress [5] through the glucose auto-oxidation, overproduction of ROS by mitochondria,
non-enzymatic glycation, and the polyol pathway [3]. FOXO transcription factors are critical
regulators of cell fate and play a major role in the oxidative stress responses modulating antiox-
idant and detoxification enzymes in order to protect the cells from ROS [7, 58, 59]. Owing to
antioxidant enzymes CAT and SOD and detoxification proteins NQO1, SFRXN and GPX-2
have an established role in the oxidative stress resistance and have been linked with FOXO1
activity as well [60], therefore, the potential modulatory effect of BITC on their gene expression
was evaluated in the frame of this work.
CAT has been described as a FOXO1 target gene, which is induced after FOXO1 activation
[60, 61]. In this study BITC reduced significantly CAT gene expression in a dose dependent
manner after 16h incubation, suggesting that another unknown pathway affected by BITC is
eventually regulating CAT gene expression. Similar results have been shown by others in liver
cells after the stimulation with resveratrol [35].
According to the analyses done in the present study, BITC had a two-phase effect in SOD
gene expression. It starts with a significant reduction (p = 0.01) at low doses of BITC (1 μM
and 5 μM), followed by a dose dependent up-regulation at higher concentrations (10–50 μM).
The down-regulation in SOD could be comparable to that reported by Zhu Y. et al. who found
a reduction of SOD activity upon the stimulation with BITC (2 μM and 5 μM) after 24h [62].
Up to the current date there are no reports evaluating the gene expression of SOD upon high
concentrations of BITC. The results suggest that SODmight be up regulated as a compensatory
response to the oxidative stress conditions produced by BITC, as observed in preliminary stud-
ies [62, 63].
The detoxification enzymes NQO1 and SRXN1were up-regulated upon BITC stimulation.
Similar results have been reported for the isothiocyanate sulforaphane, known for its NRF2
dependency in the induction of detoxification enzymes [64]. Sulforaphane promotes NRF2
nuclear import by the interaction with its cytoplasmic repressor kelch-like ECH-associated
protein 1 (KEAP1). In the nucleus NRF2 heterodimerizeswith small Maf (V-maf
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musculoaponeurotic fibrosarcoma oncogene homolog) proteins and binds to antioxidant
response elements (AREs), inducing the expression of several cytoprotective genes [64]. These
facts suggest that the effect of isothiocyanates including BITC on NRF2 modulation are regu-
lated at post-translational levels, which could explain the lack of effects on NRF2 gene expres-
sion upon BITC stimulus.
It can be concluded from the previous results that BITCmight act in the cell as a pro-oxi-
dant agent, triggering an antioxidant effect only at high concentrations, as can be deduced by
the induction in SOD, SFRXN and NQO1 gene expression after the stimulation with 30μM
BITC. As shown for other isothiocyanates [65], the pro-oxidant effect of BITC could induce
some gene and protein expression alterations through the activation of antioxidant defense sys-
tems, which could result in cell survival and adaptation [35]. However, it is clear that each anti-
oxidant is in fact a redox agent and thus might become pro-oxidant under special conditions;
this pro-oxidant actionmight not always be adverse for humans [35]. It has been proposed
that the pro-oxidant action of antioxidant vitamins and several classes of plant-derived poly-
phenols rather than their antioxidant activity, might play a crucial role in their anticancer and
apoptosis inducing properties [32, 66, 67]. During normal diet consumption, most of plant-
derived bioactive compounds would not reach toxic concentrations. Nevertheless, the concen-
trations apparently reached in vivo are sufficient to induce the activation of intracellular pro-
tective signaling pathways that have evolved to recognize potential threats by sub-toxic
concentrations of pro-oxidant bioactive compounds or electrophiles [67].
Altogether, the present study provides comprehensive insights into the effect of BITC on
the PI3K/AKT/FOXO1 pathway. BITC induces FOXO1 nuclear import and accumulation,
probably through the inhibition of AKT and FOXO1 phosphorylation. The FOXO1 nuclear
accumulation allows FOXO1 to induce oxidative stress resistance and detoxification. It could
be concluded that the gene expression of factors described as FOXO1 target genes is modulated
by additional factors in absence of FOXO1. BITC can modulate the gene expression of FOXO1
target genes by targeting, probably, other FOXO proteins, which can compensate their function
under knock-down conditions.
These results show that BITCmimics the fasting state, in which the insulin stimulus is
absent and FOXO proteins remain in the nucleus modulating gene expression of their target
genes. Although in the present study the gene expression of gluconeogenesis, antioxidant and
detoxification proteins was FOXO1 independent, one could assume that BITC targets addi-
tional transcription factors responsible for gluconeogenesis inhibition and detoxification. Since
in insulin resistant conditions insulin is not able to suppress gluconeogenesis, the inhibition of
G6pase and PEPCK by BITCmight be considered positive in type 2 diabetes prevention and
treatment. Therefore, the factors behind its modulatory effectsmerit further investigation.
Since the final purpose of the search of bioactive compounds from plants for chronic disease
prevention is their consumption by humans, the effects of BITC on T2D prevention should be
considered in in vivo studies.
Supporting Information
S1 Fig. Detoxification enzymes gene expression in HepG2 cellsmodulated by BITC. Results
are presented as fold mRNA expression, normalized to the housekeeping gene RPL32 and the
control. Data shown as + SEM (n = 3) p<0.05 (Unpaired Student’s t test).
(TIF)
S1 Video. Live cell imaging of FOXO1-GFP translocation induced by BITC in U-2 OS.U-2
OS FOXO1-GFP cells were incubated with 50 μM BITC for 1 h, the time-dependenceFOXO1
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translocation was evaluated by Live cell Imaging.
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